Identification of NF1-associated Tumor Mutations in Plasma cfDNA and its Clinical Application
Back to course
Pdf Summary
Asset Subtitle
Presenting Author - Feng Xu, PhD; Co-Author - Ariel Long, B.S.; Co-Author - Matthew Lueder, M.S.; Co-Author - Kajia Cao, Ph.D.; Co-Author - Weixuan Fu, MS; Co-Author - Zhiqian Fan, MS; Co-Author - Mateusz Koptyra, PhD; Co-Author - Jessica B. Foster, MD; Co-Author - Thomas De Raedt, PhD; Co-Author - Chelsea Kotch, MD; Co-Author - Michael J. Fisher, MD; Co-Author - Marilyn M. Li, M.D., FACMG;
Meta Tag
Cancer Syndromes
Cell free DNA/cfDNA
Genetic Testing
Genome sequencing
Genomic Methodologies
Methodology
NextGen Sequencing
Pathology
Risk Assessment
Sequencing
Co-Author Ariel Long, B.S.
Co-Author Matthew Lueder, M.S.
Co-Author Kajia Cao, Ph.D.
Co-Author Weixuan Fu, MS
Co-Author Zhiqian Fan, MS
Co-Author Mateusz Koptyra, PhD
Co-Author Jessica B. Foster, MD
Co-Author Thomas De Raedt, PhD
Co-Author Chelsea Kotch, MD
Co-Author Michael J. Fisher, MD
Co-Author Marilyn M. Li, M.D., FACMG
Presenting Author Feng Xu, PhD
Keywords
liquid biopsy assay
treatment response
malignant tumors
neurofibromatosis type 1
NF1
blood samples
plasma cfDNA
gene mutations
clinical settings
precision cancer care

© 2024 American College of Medical Genetics and Genomics. All rights reserved.

Powered By